Federation Bio Competitors and Similar CompaniesClear all
Applied Genetic Technologies's competitors and similar companies include Menlo Therapeutics and ArunA Bio.
 Applied Genetic Technologies Applied Genetic Technologies is a clinical-stage biotechnology company, which develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. |  Menlo Therapeutics Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | |
Founding Date | Founding Date 1991 | Founding Date 2011 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Alachua, US HQ Cambridge, US | Locations Redwood City, US HQ Ness Ziona, IL Bridgewater Township, US | Locations Athens, US HQ Athens, US |
Employees | Employees 859% increase | Employees 26 | Employees 274% increase |
Valuation ($) | Valuation ($) 16.9 m | Valuation ($) 39.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $325k (FY, 2022) | Revenue (est.) $570k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($68.9m) (FY, 2022) | Net income ($26.5m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 70.7m | Total funding raised $ 50m | Total funding raised $ 26.9m |
For sources of this data, please see the company profile
View Company Profiles
Menlo Therapeutics
HQ
Redwood City, US
Employees
26
Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company